Відео

10 per group pls

Nice! Thanks for sharing.

Nothing better to do

Very exciting !!! good video production with subtitle and voice over ...very nice!

where is the LTA ....

Bunch of road hazards.

good job. the pack jialat no discipline.

Wah so powerful! Liked and subscribed! 👍🏻

ride properly very hard is it?

Wow very strong and fast group ride! You did well!

Any details on this group ride to join?

hey mate! nice video :) Love the overlays!! How did you place them?

thanks for the vid...my fav route too

very nice...pure speed....

English pagujud

No stats at this age is crazy

Thanks for sharing!

It almost like a office video😍

Damn pro video brother

Can't wait for next time you all appear on newspaper when LTA does their routine weekend sweeps.

I endorse his views about China.

Comments nothing 8 months later 😅 😂😂 so in another 8 months what will be the comments of nothing again here, I’m betting it will be further failure and if it’s 10 or more I’m betting on it will be a successful or look promising turnaround and I’m betting Melo won’t be around anymore.

I feel a great deal of pity for all the morons who watch this and don’t buy this 100x stock

That a Boy. I knew you wouldn’t disappoint Jason. Just when us retail shareholders who Really Believe in your company get a glimmer of hope the stock may start rising after hit its ALL TIME LOW yesterday. What does Jason Kelly do? Sells hundreds of thousands more shares. My God man, how filthy rich are you that you need to sell millions of shares to cover your taxes??? We’re just trying to gather our little nest eggs over here pal.

Gingko Bioworks was downgraded yesterday. Gee I wonder why. The stock also plummeted 13.1%. It’s obvious the founders, Jason, Reshma and Canton do not care about shareholders. Though all three are worth over $80,000,000 each.

As if you, Jason couldn’t punish shareholders even further for believing in your mission. Today Jason announced 100,000,000 new Gingko Bioworks shares will be offered to the public. Supposedly to help fund acquisitions and other corporate purposes. Now shares are being diluted even more. Try taking a cut of yours, Reshma and Barry’s wealthy salaries to help pay for these needs and stop crushing the folks that believe in your company.

Jason Kelly make no mistake is Filthy Rich due to his exorbitant self dictated salary. He continues to Dilute shareholders, who really believe in this company, by selling Millions of shares for “tax purposes”. Jason is wiping out the little folks nest eggs with his lavish salary which forces him to sell. A multitude of shareholders are paying the price by believing in Jason and Gingko Bioworks. Nothing like getting the shaft.

What did he say? Some bs about sustainability? Blah, blah, blah. Talk about how much better your product is for your skin, that is top priority,, then tag on the good for the planet stuff to get brand loyalty. (Does he have to yell? Give the guy a microphone.)

☝🏻 *CRIMINALS*

Installed puppet, Joe Biden quietly signed a Sept. 12th 2022, executive order that further fortifies the *Transhumanist Technocratic* wet dream of our feudal dystopian overlords. This document’s Orwellian title, "Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy" will assure that none of the sheeple will ever contemplate it, let alone read it. The gene therapy jab was just the begining. 🧬🔬💉🦠 They will not stop, until they are STOPPED.

Yuval Noah Harari building his Tower of Babel. 🌩️

Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy SEPTEMBER 12, 2022 PRESIDENTIAL ACTIONS 'For biotechnology and biomanufacturing to help us achieve OUR societal goals, the United States needs to invest in foundational scientific capabilities. We need to *develop genetic engineering technologies and techniques to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers; unlock the power of biological data, including through computing tools and artificial intelligence; and advance the science of scale‑up production while reducing the obstacles for commercialization* so that innovative technologies and products can reach markets faster.' 👹